Persistent multifocal conduction block in vasculitic neuropathy with IgM anti-gangliosides

Muscle and Nerve

Volumn 36, Issue 4, 2007, Pages 547-552

  Notturno, Francesca ^a   Caporale, Christina M ^a   Di Muzio, Antonio ^a   Uncini, Antonino ^a  

^a NONE

Author keywords

Anti ganglioside antibodies; Conduction block; Nerve vasculitis; Temporal dispersion

Indexed keywords

AZATHIOPRINE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GM2; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANTIBODY LABELING; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CRYOGLOBULINEMIA; DEMYELINATION; DRUG DOSE REDUCTION; HUMAN; IMMUNOASSAY; LABORATORY DIAGNOSIS; MALE; MOTOR NERVE CONDUCTION; NERVE BIOPSY; NERVE BLOCK; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SURAL NERVE; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULITIS;

ACTION POTENTIALS; ADULT; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; MALE; NEURAL CONDUCTION; POLYNEUROPATHIES; VASCULITIS; WRIST;

EID: 34848911634     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20778     Document Type: Article

References (39)

1. Apartis E, Léger LM, Musset L, Gigenheim M, Cacoub P, Lyon-Caen, et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996;60:661-666.
2. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993;16:587-593.
3. Authier FJ, Pawlotsky JM, Viard L, Guillvin JP, Degos JD, Gherardi RK. High incidence of hepatitis C virus infection in patient with cryoglobulinemic neuropathy. Ann Neurol 1993;34:749-750.
4. Caporale CM, Papola F, Fioroni MA, Aureli A, Giovannini A, Notturno F, et al. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes. J Neuroimmunol 2006;177:112-118.
5. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral new. Neurology 1993;43:809-814.
6. Cornblath DR, Sumner AJ. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve 1991;14:184-185.
7. Fowler CJ, Gilliatt RW. Conduction velocity and conduction block after experimental ischemic nerve injury. J Neurol Sci 1981;51:221-228.
8. Gemignani F, Brindani F, Alfieri S, Giuberti T, Allegri I, Ferrari C, et al. A clinical spectrum of cryoglobulinemic neuropathy. J Neurol Neurosurg Psychiatry 2005;76:1410-1414.
9. Harvey GK, Toyka KV, Zielasek J, Kiefer P, Simonis C, Hartung HP. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural tranfer. Muscle Nerve 1995;18:388-394.
10. Hirota N, Kaji R, Bostock H, Shindo K, Kawasaki T, Mizutani K, et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain 1997;120:2159-2169.
11. Homberg V, Reiners K, Toyka KV. Reversible conduction block in human ischemic neuropathy after ergotamine abuse. Muscle Nerve 1992;15:467-470.
12. Jamieson PW, Giulíani MJ, Martínez AJ. Necrotizing angiopathy presenting with multifocal conduction blocks. Neurology 1991;41:442-444.
13. Kaji R, Hirota N, Oka N, Watanabe T, Nishio T, Kimura J. Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve 1994;17:108-110.
14. Kaku DA, Malamut RI, Frey DJ, Parry GJ. Conduction block as an early sign of reversible injury in ischemic monomelic neuropathy. Neurology 1993;43:1126-1130.
15. Ilyas AA, Li SC, Chou DKH, Li YT, Jungalwala FB, Dalakas MC, et al. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGD1a as antigen for monoclonal immunoglobulins M in neuropathy associated with gammopathy. J Biol Chem 1988;263:4369-4373.
16. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964.
17. McCluskey L, Feinberg D, Cantor C, Bird S. "Pseudo-conduction block" in vasculitic neuropathy. Muscle Nerve 1999;22:1361-1366.
18. McCluskey L, Bird S. Conduction block in vasculitic neuropathy. Muscle Nerve 1999;22:968.
19. Mizutani K, Oka N, KusunokiS, Kaj R, Mezaki T, Akiguchi I, et al. Sensorimotor demyelinating neuropathy with IgM antibody against gangliosides GD1a, GT1b and GM3. J Neurol Sci 2001;15:9-11.
20. Mohamed A, Davies L, Pollard JD. Conduction block in vasculitic neuropathy. Muscle Nerve 1998;21:1084-1088.
21. Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 2005;31:663-680.
22. Nukada H, Pollock M, Lindsay FH. Is ischemia implicated in chronic multifocal demyelinating neuropathy? Neurology 1989;39:106-110.
23. Oga T, Kusunoki S, Fujimura H, Kuboki T, Yoshida T, Takai T. Severe motor-dominant neuropathy with IgM-protein binding to the NeuAca2-3Galb-moiety. J Neurol Sci 1998;21:4-7.
24. O'Hanlon G, Veitch J, Gallardo E, Illa I, Chancellor AM, Willison HJ. Peripheral neuropathy associated with anti-GM2 ganglioside antibodies: clinical and immunopathological studies. Autoimmunity 2000;32:133-144.
25. Olney RK. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999;22(Suppl 8):S225-S229.
26. Paparounas K, O'Hanlon GM, O'Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 1999;122:807-816.
27. Parry GJ, Linn DJ. Transient focal conduction block following experimental occlusion of vasa nervorum. Muscle Nerve 1986;9:345-348.
28. Parry GJ, Linn DJ. Conduction block without demyelination following acute nerve infarction. J Neurol Sci 1988;84:265-273.
29. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JV, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
30. Rhee EK, England JD, Sumner AJ. A computer simulation of conduction block: effects produced by actual block versus interphase cancellation. Ann Neurol 1990;28:146-156.
31. Ropert A, Metral S. Conduction block in neuropathies with necrotizing vasculitis. Muscle Nerve 1990;13:102-105.
32. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992;31:385-390.
33. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner Syndrome. Muscle Nerve 1999;22:560-566.
34. Sheikh KA, Deerinck TJ, Ellisman MH, Griffin JW. The distribution of ganglioside-like moieties in peripheral nerves. Brain 1999;122:449-460.
35. Smith KJ, Hall SM. Nerve conduction during peripheral demyelination and remyelination. J Neurol Sci 1980;48:201-219.
36. Taylor BV, Dyck PJ, Engelstad J, Gruener G, Grant I, Dick PJ. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 2004;63:129-137.
37. Uncini A, England JD, Rhee EK, Duckett SW, Sumner AJ. Tellurium-induced demyelination: an electrophysiological and morphological study. Muscle Nerve 1988;11:871-879.
38. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera with anti-GM1 antibodies and multifocal motor neuropathy. Muscle Nerve1993;16:610-615.
39. Willison HJ, Yuki N. Peripheral neuropathies and anti glycolipid-antibodies. Brain 2002;125:2591-2625.